Albireo pharma, inc. (ALBO)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Jun'10
Revenue

1,549

6,431

1,385

1,250

570

571

237

730

11,202

-

-

1

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Revenue

-

-

-

-

-

-

-

-

-

-

-

-

1

3,239

28

7,973

124

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

-

Operating expenses:
Revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Research and development

16,130

14,216

11,996

11,034

8,329

9,504

9,666

6,411

6,151

3,991

3,226

2,962

2,812

1,705

2,062

2,713

1,597

1,594

1,987

5,054

2,917

3,407

2,568

3,628

4,257

3,741

3,180

3,474

2,966

4,676

4,363

2,956

2,643

2,353

2,249

2,941

2,902

5,505

5,890

Government grants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

227

207

97

296

25

29

196

-

-

0

0

-

-

-

-

-

General and administrative

8,153

6,175

6,010

5,485

5,293

5,845

3,850

4,238

4,128

4,612

3,709

3,713

3,212

10,106

1,346

3,028

1,306

1,632

1,433

1,525

1,611

1,833

1,123

1,348

1,731

1,396

1,472

1,768

2,174

1,429

1,446

1,776

1,830

2,020

2,361

2,382

2,305

2,577

2,780

Other operating expense, net

-6,816

4,109

-4,015

-8

-2,296

540

614

-487

-1,504

3,267

401

65

-74

398

-58

-290

155

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total operating expenses

31,099

16,282

22,021

16,527

15,918

14,809

12,902

11,136

11,783

5,336

6,534

6,610

6,098

11,413

3,466

6,031

2,748

3,226

3,420

6,579

4,528

5,240

3,691

4,749

5,781

5,040

4,356

5,217

5,111

5,909

5,721

4,732

4,473

4,373

4,610

5,323

5,207

8,082

8,670

Operating loss

-29,550

-9,851

-20,636

-15,277

-15,348

-14,238

-12,665

-10,406

-581

-5,337

-6,534

-6,609

-6,097

-8,174

-3,438

1,942

-2,624

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest expense, net

-1,938

-1,362

-1,274

-1,351

-1,309

-789

-1,367

-1,666

-1,016

418

23

-152

-249

227

-508

-512

-526

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-operating income (expense), net

-

-

-

-

-

-817

7

-2,531

-22

75

0

585

-325

-3,211

-84

709

-89

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest and other income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

15

12

220

17

18

18

7

9

9

11

13

16

17

11

12

16

24

15

17

24

30

20

5

5

3

Interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

-

0

0

-

-

Adjustments to fair value of common stock warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6

-4

0

2

178

119

166

546

1,399

1,548

-426

2,586

3,536

-4,431

-116

2,228

-156

-1,355

146

-145

8,721

1,355

-237

2,772

-

Loss on settlement of debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

-

0

-

-

-

Net loss before income taxes

-

-

-

-

-

-

-

-

-1,619

-4,844

-6,511

-6,176

-6,671

-11,158

-4,030

2,139

-3,239

-3,207

-3,226

-6,442

-4,355

-4,685

-2,283

-3,190

-6,194

-2,438

-803

-9,637

-5,215

-3,665

-5,853

-6,072

-4,310

-4,494

4,141

-3,948

-5,439

-5,305

-8,667

Income tax

-

-

-

-

-

-

-

-

0

212

0

0

0

62

0

0

0

8

6

20

1

2

3

14

4

5

12

-6

5

4

26

-21

6

7

9

26

3

3

-38

Net loss

-31,488

-7,522

-21,910

-16,628

-16,657

-15,864

-14,025

-14,603

-1,619

-5,056

-6,511

-6,176

-6,671

-11,220

-4,030

2,139

-3,239

-3,215

-3,232

-6,462

-4,356

-4,687

-2,286

-3,204

-6,198

-2,443

-815

-9,631

-5,220

-3,669

-5,879

-6,051

-4,316

-4,501

4,132

-3,974

-5,442

-5,308

-

Net loss per share - basic

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-13.32

7.42

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss per share - diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-13.32

0.69

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted average shares outstanding - basic

-

-

-

-

-

-

-

-

-

-

-

-

-

-

302

288

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted average shares outstanding - diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

302

3,101

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss per share attributable to holders of common stock:
Net loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-8,629

Charge for accretion of beneficial conversion rights

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

-

0

-

-

-

Deemed dividend - warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

-

0

-

-

-

Net loss applicable to common stockholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-5,220

-3,669

-5,879

-6,051

-4,316

-4,501

4,132

-3,974

-5,442

-5,308

-8,629

Net loss per common share - basic and diluted

-2.23

-0.57

-1.73

-1.35

-1.39

-1.40

-1.17

-1.22

-0.15

-0.47

-0.73

-0.86

-1.06

-6.79

-6.26

12.06

-12.20

-0.05

-13.20

-0.12

-0.18

-0.20

-0.10

-0.15

-0.29

-0.12

0.05

-0.66

-0.37

-0.26

-0.47

-0.52

-0.45

-0.47

-0.47

-0.48

-0.21

-0.20

-0.36

Weighted-average shares outstanding:
Weighted-average common shares used to compute basic and diluted net loss per common share

14,132

12,708

12,685

12,355

12,001

12,006

11,969

11,938

10,896

8,934

8,878

7,171

6,292

60,007

-183,340

128,026

265

63,583

-96,229

53,893

24,369

23,435

22,341

21,118

21,083

21,073

19,670

14,573

14,182

14,176

12,568

11,600

9,688

9,673

-

8,254

26,469

-

-

Weighted average shares outstanding - basic and diluted (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

26,419

23,944